Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of the Safety and Efficacy of Pimavanserin (ACP-103) in Patients With Parkinson's Disease Psychosis

ClinicalTrials.gov ID: NCT00477672

Public ClinicalTrials.gov record NCT00477672. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 27, 2026, 6:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Placebo-Controlled, Double-Blind Trial to Examine the Safety and Efficacy of ACP-103 in the Treatment of Psychosis in Parkinson's Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the safety and efficacy of two dose levels of pimavanserin (ACP-103) compared to placebo in patients with Parkinson's disease psychosis.

Study identification

NCT ID
NCT00477672
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
ACADIA Pharmaceuticals Inc.
Industry
Enrollment
298 participants

Conditions and interventions

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2007
Primary completion
May 31, 2009
Completion
Jun 30, 2009
Last update posted
May 16, 2017

2007 – 2009

United States locations

U.S. sites
36
U.S. states
18
U.S. cities
36
Facility City State ZIP Site status
Not listed Gilbert Arizona 85234 —
Not listed Phoenix Arizona 85013 —
Not listed Berkeley California 94705 —
Not listed Carson California 90746 —
Not listed Fountain Valley California 92708 —
Not listed Irvine California 92697 —
Not listed Sunnyvale California 94805 —
Not listed Danbury Connecticut 06810 —
Not listed Fairfield Connecticut 06824 —
Not listed Boca Raton Florida 33486 —
Not listed Gainesville Florida 32610 —
Not listed Jacksonville Florida 32209 —
Not listed Miami Florida 33136 —
Not listed Pompano Beach Florida 33060 —
Not listed Port Charlotte Florida 33952 —
Not listed Sarasota Florida 34239 —
Not listed St. Petersburg Florida 33701 —
Not listed Tampa Florida 33606 —
Not listed Augusta Georgia 30912 —
Not listed Springfield Illinois 62794 —
Not listed Scarborough Maine 04074 —
Not listed Worcester Massachusetts 01655 —
Not listed Southfield Michigan 48034 —
Not listed Traverse City Michigan 49684 —
Not listed Toms River New Jersey 08755 —
Not listed Kingston New York 12401 —
Not listed Rochester New York 14618 —
Not listed Asheville North Carolina 28806 —
Not listed Salisbury North Carolina 28144 —
Not listed Columbus Ohio 43210 —
Not listed Warwick Rhode Island 02886 —
Not listed Brentwood Tennessee 37027 —
Not listed San Antonio Texas 78258 —
Not listed Richmond Virginia 23229 —
Not listed Kirkland Washington 98034 —
Not listed Spokane Washington 99204 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 42 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00477672, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 16, 2017 · Synced Sep 27, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00477672 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →